Therapy News and Research

RSS

Study: Ketogenic diet helps kill pancreatic cancer cells when combined with a triple-drug therapy

The findings of a new study suggest that a ketogenic diet - which is low in carbohydrates and protein, but high in fat - helps to kill pancreatic cancer cells when combined with a triple-drug therapy developed by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

22 Mar 2022

Researchers receive a combined $1 million grant to study RET-positive lung cancer

University of Colorado Cancer Center member Tejas Patil, MD, is one of three researchers to receive a combined $1 million grant from the Hamoui Foundation and LUNGevity Foundation to study RET-positive lung cancer.

21 Mar 2022

Novel screening platform flags 95% of stage 1 cancers

A novel screening platform has flagged more than 95 percent of stage 1 cancers, according to a pilot study published in Nature Communications Medicine. If validated by future studies, the approach offers a new way to detect the third-leading cause of U.S. cancer deaths in 2020.

21 Mar 2022

Trial reveals effectiveness of axi-cel as first-line treatment for high-risk lymphoma

Results from the ZUMA-12 trial led by researchers at The University of Texas MD Anderson Cancer Center showed that first-line treatment with axicabtagene ciloleucel (axi-cel), a chimeric antigen receptor (CAR) T cell therapy, achieved a high rate of complete response in patients with high-risk large B-cell lymphoma (LBCL).

21 Mar 2022

Covid-19 patients are at increased risk of developing type 2 diabetes, study shows

People who have had Covid-19 are at increased risk of developing type 2 diabetes. This is the result of a study by DDZ, DZD and IQVIA, which has now been published in Diabetologia.

21 Mar 2022

New test greatly simplifies the diagnosis of allergies

Although allergies are widespread, their diagnosis is complex and, depending on the type of allergy, the prospects of success with therapy are not always clear.

21 Mar 2022

NIH launches Molecular Characterization Initiative for pediatric tumors

In support of President Biden's Cancer Moonshot℠ goal of fostering data sharing in cancer research, the National Cancer Institute, part of the National Institutes of Health, has launched the Molecular Characterization Initiative for pediatric tumors.

21 Mar 2022

Money flows into addiction tech, but will it curb soaring opioid overdose deaths?

David Sarabia had already sold two startups by age 26 and was sitting on enough money to never have to work another day in his life.

21 Mar 2022

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

A Phase I/Ib trial conducted by the National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group NRG Oncology, NRG-GY017, concluded that the addition of the immunotherapy drug atezolizumab prior to and concurrently given with chemoradiation (CRT) treatment was safe for women with node-positive, locally advanced cervical cancer.

19 Mar 2022

Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in 75% of patients with recurrent or persistent estrogen receptor- (ER-) positive endometrial cancer, results from a recent clinical trial show.

19 Mar 2022

Women less likely to receive lifesaving intervention for cardiogenic shock than men

Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology.

19 Mar 2022

A single gene can control brain cell growth in humans, research shows

Controlling how cells grow is fundamental to ensuring proper brain development and stopping aggressive brain tumors.

19 Mar 2022

Understanding how coronavirus, RS virus and rhinovirus affect children

When Inger Heimdal started studying the coronavirus in children in 2014, not many people thought the topic sounded particularly exciting.

18 Mar 2022

Study: Targeting astrocytes reduces tau-related brain damage and inflammation in mice

Alzheimer's disease is the most common and best known of the tauopathies, a set of neurodegenerative brain diseases caused by toxic tangles of the protein tau.

18 Mar 2022

New method for generating lung tissue from just a few body cells in the lab

Laboratory studies of lung tissue usually require the removal of large amounts of human or animal tissue. Now scientists from the University of Freiburg's Faculty of Medicine have succeeded in collaboration with American researchers in generating tiny quantities of lung tissue, so-called organoids, from just a few body cells in the lab.

18 Mar 2022

Developing an autonomous robotic platform to improve the quality of sleep

For World Sleep Day, we speak to Alexander Breuss from the Sensory-Motor Systems Lab about their autonomous robotic sleep platform.

18 Mar 2022

World Sleep Day: Diagnosing chronic respiratory diseases from within the bedroom

For World Sleep Day 2022, News-Medical speaks to Max Sieghold, Co-Founder and CFO of Sleepiz, about their technology and its ability to diagnose sleep apnea/

18 Mar 2022

New research project aims to investigate the different 'languages' used by viruses

The different "languages" used by viruses will be investigated by a new research project at the University of Exeter.

18 Mar 2022

New approach radically increases the success of breast cancer immunotherapy

A study published in the journal Nature Cancer, carried out within the Cancer Programme at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) by the Cancer Stem Cells and Metastasis Dynamics Laboratory, led by Dr. Toni Celià-Terrassa, and the Laboratory of Molecular Cancer Therapy, coordinated by Dr. Joan Albanell, with the participation of international centers, has discovered an approach that radically increases the success of immunotherapy in one of the most aggressive types of tumors, triple-negative breast cancer.

17 Mar 2022

Two clever human antibodies can target Ebola and Sudan virus

Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its deadly relatives.

17 Mar 2022

Therapy News and Research

Study: Ketogenic diet helps kill pancreatic cancer cells when combined with a triple-drug therapy

Researchers receive a combined $1 million grant to study RET-positive lung cancer

Novel screening platform flags 95% of stage 1 cancers

Trial reveals effectiveness of axi-cel as first-line treatment for high-risk lymphoma

Covid-19 patients are at increased risk of developing type 2 diabetes, study shows

New test greatly simplifies the diagnosis of allergies

NIH launches Molecular Characterization Initiative for pediatric tumors

Money flows into addiction tech, but will it curb soaring opioid overdose deaths?

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

Women less likely to receive lifesaving intervention for cardiogenic shock than men

A single gene can control brain cell growth in humans, research shows

Understanding how coronavirus, RS virus and rhinovirus affect children

Study: Targeting astrocytes reduces tau-related brain damage and inflammation in mice

New method for generating lung tissue from just a few body cells in the lab

Developing an autonomous robotic platform to improve the quality of sleep

World Sleep Day: Diagnosing chronic respiratory diseases from within the bedroom

New research project aims to investigate the different 'languages' used by viruses

New approach radically increases the success of breast cancer immunotherapy

Two clever human antibodies can target Ebola and Sudan virus

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News